TCRX

Tscan Therapeutics Inc

Jun 16 • 04:00PM ET

0.8481

-0.1023 -10.76 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ANVS EXOZ FBIO ICCC MCRB PLRX PMVP QTTB RLYB XBIT

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	14.15%	Shs Outstand	65.35M	Perf Week	-12.16%
Market Cap	55.42M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	1.78%	Shs Float	56.10M	Perf Month	-15.19%
Enterprise Value	19.90M	PEG	-	EPS next Q	-0.26	Inst Own	47.86%	Short Float	1.67%	Perf Quarter	-22.19%
Income	-124.31M	P/S	6.06	EPS this Y	-5.40%	Inst Trans	1.88%	Short Ratio	1.15	Perf Half Y	-16.03%
Sales	9.14M	P/B	0.53	EPS next Y	8.35%	ROA	-46.50%	Short Interest	0.93M	Perf YTD	-15.19%
Book/sh	1.61	P/C	0.43	EPS next 5Y	5.09%	ROE	-80.95%	52W High	2.57 -67.00%	Perf Year	-44.57%
Cash/sh	1.96	P/FCF	-	EPS past 3/5Y	28.66% 2.08%	ROIC	-68.29%	52W Low	0.88 -3.89%	Perf 3Y	-68.70%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.63% 56.92%	Gross Margin	68.48%	Volatility	8.63% 6.77%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.18	EPS Y/Y TTM	12.20%	Oper. Margin	-1408.73%	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.65	Sales Y/Y TTM	106.65%	Profit Margin	-1360.61%	RSI (14)	32.59	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	6.65	EPS Q/Q	16.19%	SMA20	-14.39%	Beta	1.06	Target Price	6.00
Payout	-	Debt/Eq	0.95	Sales Q/Q	-54.77%	SMA50	-22.53%	Rel Volume	1.00	Prev Close	0.95
Employees	142	LT Debt/Eq	0.88	Earnings	May 06 BMO	SMA200	-33.52%	Avg Volume	815.98K	Price	0.85
IPO	Jul 16, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-8.64% -60.72%	Trades		Volume	812,273	Change	-10.76%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)